Browse our anti-NFKB1 (NFKB1) Antibodies

Full name:
anti-Nuclear Factor of kappa Light Polypeptide Gene Enhancer in B-Cells 1 Antibodies (NFKB1)
On www.antibodies-online.com are 578 Nuclear Factor of kappa Light Polypeptide Gene Enhancer in B-Cells 1 (NFKB1) Antibodies from 35 different suppliers available. Additionally we are shipping NFKB1 Kits (77) and NFKB1 Proteins (19) and many more products for this protein. A total of 723 NFKB1 products are currently listed.
Synonyms:
BICDR-1, bicdr1, ccdc64, EBP-1, KBF1, NF-kappa-B, NF-kappaB, NF-kappaB1, NF-kB, NF-kB1, NFkappaB, NFKB-p50, NFKB-p105, p50, p50/p105, p105
list all antibodies Gene Name GeneID UniProt
NFKB1 18033 P25799
NFKB1 4790 P19838
NFKB1 81736  

Show all species

Show all synonyms

Most Popular Reactivities for anti-NFKB1 (NFKB1) Antibodies

Select your species and application

anti-Mouse (Murine) NFKB1 Antibodies:

anti-Human NFKB1 Antibodies:

anti-Rat (Rattus) NFKB1 Antibodies:

All available anti-NFKB1 Antibodies

Go to our pre-filtered search.

Top referenced anti-NFKB1 Antibodies

  1. Human Polyclonal NFKB1 Primary Antibody for IHC, ELISA - ABIN1532952 : Baeuerle, Baltimore: NF-kappa B: ten years after. in Cell 1996 (PubMed)
    Show all 2 references for 1532952

  2. Human Polyclonal NFKB1 Primary Antibody for IF, IHC - ABIN1532954 : Haskill, Beg, Tompkins, Morris, Yurochko, Sampson-Johannes, Mondal, Ralph, Baldwin: Characterization of an immediate-early gene induced in adherent monocytes that encodes I kappa B-like activity. in Cell 1991 (PubMed)
    Show all 2 references for 1532954

  3. Human Polyclonal NFKB1 Primary Antibody for DB - ABIN650886 : Pan, Li, Huang, Papadimos, Pan, Chen: Synergistic activation of NF-{kappa}B by bacterial chemoattractant and TNF{alpha} is mediated by p38 MAPK-dependent RelA acetylation. in The Journal of biological chemistry 2010 (PubMed)
    Show all 2 references for 650886

  4. Human Polyclonal NFKB1 Primary Antibody for WB - ABIN411544 : Fu, Wang, Zhao, Yu, Li, Lin, Liang, Huang, Liang, Han, Qin: FHL1C induces apoptosis in Notch1-dependent T-ALL cells through an interaction with RBP-J. in BMC cancer 2014 (PubMed)

  5. Cow (Bovine) Polyclonal NFKB1 Primary Antibody for WB - ABIN2792232 : Droll, Song, Krohn, Muehlberg, Alt: TNFalpha protects tissue resident stem cells from H2O2 induced apoptosis through a novel NF-small ka, CyrillicB p50/p50 homodimer mediated signaling pathway. in Biochemical and biophysical research communications 2008 (PubMed)

  6. Cow (Bovine) Polyclonal NFKB1 Primary Antibody for IHC, WB - ABIN2780565 : Heinemann, Biesinger, Fleckenstein, Albrecht: NFkappaB signaling is induced by the oncoprotein Tio through direct interaction with TRAF6. in The Journal of biological chemistry 2006 (PubMed)

More Antibodies against NFKB1 Interaction Partners

Rhesus Monkey Nuclear Factor of kappa Light Polypeptide Gene Enhancer in B-Cells 1 (NFKB1) interaction partners

  1. TRIM5alpha (show TRIM5 Antibodies) represses HIV-1 LTR promoter activity by negatively regulating TAK1 (show NR2C2 Antibodies)/TAB1 (show TAB1 Antibodies)/TAB2 (show TAB2 Antibodies)/TAB3 (show TAB3 Antibodies)-complex-mediated NF-kappaB activation.

Mouse (Murine) Nuclear Factor of kappa Light Polypeptide Gene Enhancer in B-Cells 1 (NFKB1) interaction partners

  1. The present results suggest that Fas (show FAS Antibodies)/S1P1 (show S1PR1 Antibodies) signaling via activation of NF-kappaB in osteoclast precursor cells is a key factor in the pathogenesis of rheumatoid arthritis in the temporomandibular joint.

  2. Antioxidative fraction of white mulberry (Morus alba) was found to have an apotogenic effect on Ehrlich's ascites carcinoma cell-induced mice (EAC (show CYLD Antibodies) mice) that correlate with upregulated tumor suppressor protein p53 (p53 (show TP53 Antibodies)) and downregulated NF-kappa B (NFkappaB) signaling.

  3. asthma group had significantly higher mRNA expression of HMGB1 (show HMGB1 Antibodies), TLR4 (show TLR4 Antibodies), and NF-kappaB in lung tissues than the control group, and the intervention group had significantly lower mRNA expression of TLR4 (show TLR4 Antibodies) and NF-kappaB than the asthma group

  4. miR (show MLXIP Antibodies)-23a-5p modulated the innate host defense by promoting mycobacteria survival and inhibiting the activation of autophagy against Mycobacterium tuberculosis through TLR2 (show TLR2 Antibodies)/MyD88 (show MYD88 Antibodies)/NF-kappaB pathway by targeting TLR2 (show TLR2 Antibodies).

  5. LIGHT signalling pathway combined with IFN-gamma (show IFNG Antibodies) induces beta cells apoptosis via an NF-kappaB/Bcl2 (show BCL2 Antibodies)-dependent mitochondrial pathway.

  6. The mRNA expression of TLR4 (show TLR4 Antibodies) and NF-kappaB is increased in a neonatal murine model of necrotizing enterocolitis.

  7. NF-kappaB and c-Jun (show JUN Antibodies) coregulate lipopolysaccharide-induced Fra-1 (show FOSL1 Antibodies) transcription.

  8. Findings reveal a novel role for Par-4 (show F2RL3 Antibodies)/NF-kappaB in islet beta cell apoptosis and type 2 diabetes.

  9. The production of inflammatory mediators of IL-6 (show IL6 Antibodies) and COX-2 (show COX2 Antibodies) was also significantly attenuated when treated with 1. It may be attributed to inhibiting NFkappaB signaling. Moreover, this polyphenol suppressed p-STAT3 (show STAT3 Antibodies) production as well as its downstream proteins response for apoptosis, such as Bcl-2 (show BCL2 Antibodies) and Bax (show BAX Antibodies). In summary, the study not only afforded our understanding involved in colitis, but also provided the possible thera...

  10. Dexamethasone-induced MuRF1 (show TRIM63 Antibodies) upregulation was significantly attenuated in C2C12 myotubes by resveratrol in vitro, but this effect on C2C12 myotubes was abrogated by a knockdown of NF-kappaB, suggesting that the beneficial effect of resveratrol was NF-kappaB dependent. Our findings provide novel information about the ability of resveratrol to prevent or treat muscle atrophy induced by CKD.

Human Nuclear Factor of kappa Light Polypeptide Gene Enhancer in B-Cells 1 (NFKB1) interaction partners

  1. These results demonstrate for the first time that primary human monocyte Exos enter endothelial cells and cause dysfunction via the TLR4 (show TLR4 Antibodies) and NF-kappaB pathways, which may contribute to heart disease in HIV infection and other diseases involving chronic immune activation.

  2. RAC1b (show RAC3 Antibodies) overexpression stimulates proliferation and NF-kappaB-mediated anti-apoptotic signaling in thyroid cancer cells.

  3. GW3965 significantly increases the expression of liver X nuclear receptor beta (show NR1H2 Antibodies) (LXRbeta (show NR1H2 Antibodies)) mRNA, while the liver X nuclear receptor alpha (LXRalpha (show NR1H3 Antibodies)( mRNA expression did not change a lot, and sensitizes gefitinib by inhibiting NF-kappa B (NF-kappaB) activation.

  4. Data indicate that interleukin 1alpha (IL-1alpha) propiece can activate NF-kappa B (NFkappaB) and Sp1 transcription factor (SP1 (show SP1 Antibodies)).

  5. NF-kappaB and beta-catenin (show CTNNB1 Antibodies) signaling by gain-of-function mutations in CARMA1 (show CARD11 Antibodies) augments WNT (show WNT2 Antibodies) stimulation and is required for regulating the expression of distinct NF-kappaB target genes to trigger cell-intrinsic and extrinsic processes that promote DLBCL lymphomagenesis

  6. These results suggest a preponderant role for the protein S100-A9 (show S100A9 Antibodies) as an activator of the NF-kappa B pathway during Chronic lymphocytic leukemia progression and suggest that the leukemic clone can generate an autoactivation loop through S100-A9 expression, NF-kappa B activation, and exosome secretion.

  7. Data suggest that human regulatory T-lymphocytes express DR3 (show TNFRSF25 Antibodies) and demonstrate DR3 (show TNFRSF25 Antibodies)/TL1A (show TNFSF15 Antibodies)-mediated activation of signaling via MAP kinases and NFkappaB. (DR3 (show TNFRSF25 Antibodies) = death receptor 3 (show TNFRSF25 Antibodies); TL1A/TNFSF15 (show TNFSF15 Antibodies) = tumor necrosis factor (show TNF Antibodies) [ligand] superfamily, member 15)

  8. Data indicate that ellagic aicd (EA) down-regulates the expression of COX-2 (show COX2 Antibodies), NF-kappa B, vimentin (show VIM Antibodies) and up-regulates the expression of E-cadherin (show CDH1 Antibodies) in in pancreatic carcinom PANC-1 cells.

  9. an interconnected network of TG2 (show TGM2 Antibodies)/NF-kappaB and IL6 (show IL6 Antibodies)/STAT3 (show STAT3 Antibodies) signaling with autophagy regulation in MCL (show FH Antibodies) cells.

  10. Low NFKB1 expression is associated with graft-versus-host disease.

Zebrafish Nuclear Factor of kappa Light Polypeptide Gene Enhancer in B-Cells 1 (NFKB1) interaction partners

  1. Study indicate an essential role of NF-kappaB in gonadal differentiation.

Pig (Porcine) Nuclear Factor of kappa Light Polypeptide Gene Enhancer in B-Cells 1 (NFKB1) interaction partners

  1. inhibition of NF-kappaB increases autophagy via JNK (show MAPK8 Antibodies) signaling, and promotes steroidogenesis in porcine granulosa cells

  2. SIRT1 (show SIRT1 Antibodies), p53 (show TP53 Antibodies) and NF-kappaB are involved in the control of both the proliferation and the apoptosis of ovarian cells.

  3. porcine CD74 (show CD74 Antibodies) significantly enhanced the inflammatory response by regulating the NF-kappaB signalling pathway during PCV2 infection, which suggests that porcine CD74 (show CD74 Antibodies) may be implicated in the pathogenesis of PCV2 infection.

  4. These results suggest that trans-10, cis (show CISH Antibodies)-12-conjugated linoleic acid can modulate TNF-alpha (show TNF Antibodies) production and NF-kappa B expression by a PPARgamma (show PPARG Antibodies)-dependent pathway in porcine peripheral blood mononuclear cells.

Cow (Bovine) Nuclear Factor of kappa Light Polypeptide Gene Enhancer in B-Cells 1 (NFKB1) interaction partners

  1. Taken together, Staphylococcus aureus induces TGF-beta1 (show TGFB1 Antibodies) and bFGF (show FGF2 Antibodies) expression through the activation of AP-1 (show JUN Antibodies) and NF-kappaB in bovine mammary gland fibroblasts.

  2. Data indicate the involvement of PKC-alpha (show PKCa Antibodies) in proMMP-2 activation and inhibition of TIMP-2 (show TIMP2 Antibodies) expression by NF-kappaB-MT1-MMP (show MMP14 Antibodies)-dependent and -independent pathway.

  3. MMP-1 (show MMP1 Antibodies) promotes VEGFR2 (show KDR Antibodies) expression and proliferation of endothelial cells through stimulation of PAR-1 (show F2R Antibodies) and activation of NF-kappaB

  4. dynamic compression stimulates cell proliferation and proteoglycan (show Vcan Antibodies) synthesis in the presence of IL-1beta (show IL1B Antibodies) and/or inhibitors of the MAPKs and NFkappaB and AP-1 (show JUN Antibodies) signalling pathways

NFKB1 Antigen Profile

Antigen Summary

This gene encodes a 105 kD protein which can undergo cotranslational processing by the 26S proteasome to produce a 50 kD protein. The 105 kD protein is a Rel protein-specific transcription inhibitor and the 50 kD protein is a DNA binding subunit of the NF-kappa-B (NFKB) protein complex. NFKB is a transcription regulator that is activated by various intra- and extra-cellular stimuli such as cytokines, oxidant-free radicals, ultraviolet irradiation, and bacterial or viral products. Activated NFKB translocates into the nucleus and stimulates the expression of genes involved in a wide variety of biological functions. Inappropriate activation of NFKB has been associated with a number of inflammatory diseases while persistent inhibition of NFKB leads to inappropriate immune cell development or delayed cell growth. Two transcript variants encoding different isoforms have been found for this gene.

Alternative names and synonyms associated with NFKB1

  • nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (nfkb1) antibody
  • nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (NFKB1) antibody
  • nuclear factor NF-kappa-B p105 subunit (CpipJ_CPIJ012236) antibody
  • nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 (Nfkb1) antibody
  • nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (Nfkb1) antibody
  • BICDR-1 antibody
  • bicdr1 antibody
  • ccdc64 antibody
  • EBP-1 antibody
  • KBF1 antibody
  • NF-kappa-B antibody
  • NF-kappaB antibody
  • NF-kappaB1 antibody
  • NF-kB antibody
  • NF-kB1 antibody
  • NFkappaB antibody
  • NFKB-p50 antibody
  • NFKB-p105 antibody
  • p50 antibody
  • p50/p105 antibody
  • p105 antibody

Protein level used designations for NFKB1

nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105) , nuclear factor NF-kappa-B p105 subunit , nuclear factor kappa-B, subunit 1 , nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 , nuclear factor NF-kappa-B p105 subunit-like , DNA-binding factor KBF1 , EBP-1 , NF kappaB1 , NF-kappa-B1 p84/NF-kappa-B1 p98 , NF-kappaB p50 , nuclear factor kappaB p50 , nuclear factor of kappa light chain gene enhancer in B-cells 1, p105 , nuclear factor of kappa light polypeptide gene enhancer in B-cells 1, p105 , nuclear factor-kappaB p50 , p50 subunit of NF kappaB , p50 subunit of NF-kappaB , DNA binding factor KBF1 , NF-kappabeta , nuclear factor NF-kappa-B p50 subunit , nuclear factor kappa-B DNA binding subunit , BICD-related protein 1 , NF-kB1 precursor protein , bicaudal D-related protein 1 , coiled-coil domain-containing protein 64A , p50 , NF-kB p50 subunit , nuclear factor kappa-B 1 , nuclear factor of kappa light polypeptide enhancer in B-cells 1

GENE ID SPECIES
447632 Xenopus laevis
461406 Pan troglodytes
710324 Macaca mulatta
100142683 Felis catus
100415321 Callithrix jacchus
100461595 Pongo abelii
6044826 Culex quinquefasciatus
100581655 Nomascus leucogenys
18033 Mus musculus
4790 Homo sapiens
565756 Danio rerio
396033 Gallus gallus
442859 Canis lupus familiaris
751869 Sus scrofa
616115 Bos taurus
81736 Rattus norvegicus
100730075 Cavia porcellus
Selected quality suppliers for anti-NFKB1 (NFKB1) Antibodies
Did you look for something else?